We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

17 hedge funds and large institutions have $21.9M invested in VolitionRx Ltd in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

6% more funds holding

Funds holding: 16 → 17 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.03% less ownership

Funds ownership: 0.95% → 0.92% (-0.03%)

8% less capital invested

Capital invested by funds: $23.9M → $21.9M (-$1.95M)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
6
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$737K
2
LIM
Lagoda Investment Management
New York
+$659K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$62.8K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$46.4K
5
Bessemer Group
Bessemer Group
New Jersey
+$44.8K

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$125K
2
Morgan Stanley
Morgan Stanley
New York
-$17.9K
3
BlackRock
BlackRock
New York
-$5K
4
UBS Group
UBS Group
Switzerland
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$14.1M +$659K +7,345 +5%
SCA
2
Southpoint Capital Advisors
New York
$3.66M – – –
KCM
3
Knoll Capital Management
Florida
$2.09M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$927K +$737K +8,219 +429%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$461K – – –
Morgan Stanley
6
Morgan Stanley
New York
$274K -$17.9K -200 -6%
GBA
7
Garrison Bradford & Associates
New York
$71K – – –
Northern Trust
8
Northern Trust
Illinois
$64K +$2.24K +25 +4%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$64K +$62.8K +700 New
Creative Planning
10
Creative Planning
Kansas
$62K +$1.34K +15 +2%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$47K +$46.4K +517 New
Bessemer Group
12
Bessemer Group
New Jersey
$46K +$44.8K +500 New
AG
13
Advisor Group
Arizona
$34K – – –
BA
14
BlackRock Advisors
Delaware
$29K – – –
AIM
15
Acrospire Investment Management
Illinois
$20K +$12.1K +135 +159%
BFA
16
BlackRock Fund Advisors
California
$14K +$2.42K +27 +21%
IP
17
Intellectus Partners
California
$1K +$1.26K +14 New
VKH
18
Virtu KCG Holdings
New York
– -$125K -1,176 Closed
BlackRock
19
BlackRock
New York
– -$5K -50 Closed
UBS Group
20
UBS Group
Switzerland
– -$5K -50 Closed

VNRX Hedge Fund Activity: Q4 2016 in Review

17 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2016, worth a combined $21.9M — down 8.2% from $23.9M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new VNRX positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $737K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $125K sold.

  • 17 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2016, up from 16 in Q3 2016.
  • Funds reported $21.9M of VolitionRx Ltd stock for Q4 2016, down 8.2% quarter-over-quarter.
  • 4 funds opened new VolitionRx Ltd positions in Q4 2016 and 3 closed out, a net change of +1 holder.
  • The largest VolitionRx Ltd buyer in Q4 2016 was Vanguard Group, an estimated $737K added.
  • The largest VolitionRx Ltd seller in Q4 2016 was Virtu KCG Holdings, an estimated $125K sold.

Based on aggregated 13F filings for Q4 2016.